These data demonstrate that NDGA does not act as an inhibitor of the EGFR kinase or the activation of the Ras/Raf/ERK- or the Ras/PI3-kinase/AKT/p70s6k signalling pathways in pancreatic and cervical cancer cells. Here, RPS6KB1 is linked to cervical cancer.